Tag

Cobenfy

All articles tagged with #cobenfy

Bristol Myers Stock Rises Amid Delays and Updates on Alzheimer’s Drug Trials

Originally Published 1 month ago — by Investor's Business Daily

Bristol Myers Squibb's stock rose over 5% after delaying the results of a clinical trial for Cobenfy, a drug for Alzheimer's disease psychosis, due to enrollment irregularities. The delay, expected to extend the trial completion to 2026, suggests positive trends despite concerns, and the stock's movement reflects investor optimism about the potential market and ongoing development efforts.

business business alzheimers-disease-psychosis bristol-myers-squibb business clinical-trial-delay cobenfy stock-market

New Drug and Treatment Insights Improve Schizophrenia and Psychosis Outcomes

Originally Published 2 months ago — by Neuroscience News

A study analyzing real-world data suggests that the new schizophrenia drug Cobenfy is most effective for patients with negative symptoms like social withdrawal, supporting the move toward precision psychiatry by identifying biological subtypes of psychosis that respond differently to treatment.

health health biological-subtypes cobenfy health personalized-medicine psychosis schizophrenia